PLATELET AGGREGATION INHIBITION

This adverse event was reported 92 times

These drugs are most commonly taken by patients reporting PLATELET AGGREGATION INHIBITION:

# Drug Count
0 ASPIRIN 25
1 ASPIRIN 325 MG 23
2 ASPIRIN 81 MG 23
3 ADRENALINUM 15
4 BUPIVACAINE 15
5 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 15
6 EPINEPHRINE 15
7 ESCITALOPRAM 14
8 ESCITALOPRAM OXALATE 14
9 ESCITSLOPRAM 14
See all common drugs associated with PLATELET AGGREGATION INHIBITION

PLATELET AGGREGATION INHIBITION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 HETASTARCH 3 0.0176
1 MILRINONE LACTATE 4 0.0144
2 SEVELAMER HYDROCHLORIDE 3 0.0052
3 SORBITOL 3 0.0050
4 LIDOCAINE HCL 3% 1 0.0022
5 BUPIVACAINE HYDROCHLORIDE IN DEXTROSE 15 0.0020
6 SODIUM POLYSTYRENE SULFONATE 3 0.0019
7 BUPIVACAINE 15 0.0016
8 PRASUGREL HYDROCHLORIDE 10 0.0010
9 ANAGRELIDE HYDROCHLORIDE 1 0.0009
See all drugs enriched for association with PLATELET AGGREGATION INHIBITION

PLATELET AGGREGATION INHIBITION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Volume Expander [EPC] 3 0.0010
1 Ester Local Anesthetic [EPC] 13 0.0003
2 Potassium Binder [EPC] 3 0.0002
3 Amide Local Anesthetic [EPC] 16 0.0002
4 Catecholamine [EPC] 15 0.0002
5 Non-Standardized Chemical Allergen [EPC] 13 0.0002
6 Antiarrhythmic [EPC] 16 0.0002
7 P2Y12 Platelet Inhibitor [EPC] 18 0.0002
8 Provitamin D2 Compound [EPC] 2 0.0001
9 Dipeptidyl Peptidase 4 Inhibitor [EPC] 2 0.0001
See all drug classes enriched for association with PLATELET AGGREGATION INHIBITION